−0.000 BRL
207.67 M BRL
3.19 B BRL
About Repligen Corporation
Sector
CEO
Olivier Dominique Loeillot
Headquarters
Waltham
Website
Founded
1981
ISIN
BRR2GEBDR001
FIGI
BBG014XKL265
Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the North America. Europe, and Asia Pacific Region or Other geographical segments. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.
Displays a symbol's price movements over previous years to identify recurring trends.